Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Clinical trial NCT04380220 · UNKNOWN
Trial details
- NCT number
- NCT04380220
- Sponsor
- Regina Elena Cancer Institute
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-09-07
- Primary completion
- 2020-08-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.